Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22 | 18 | 113 | 9 | 217 |
| TOTAL | $31 | $38 | $149 | $227 | $420 |
| Non-Current Assets | |||||
| PPE Net | 7 | 9 | 11 | 13 | 16 |
| Investments And Advances | 0 | 0 | 0 | 300 | 300 |
| Other Non-Current Assets | 0 | 0 | 10 | 10 | 10 |
| TOTAL | $7 | $9 | $21 | $323 | $326 |
| Total Assets | $37 | $47 | $170 | $551 | $746 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,791 | 1,621 | 1,518 | 1,350 | 1,204 |
| Accrued Expenses | 1,095 | 968 | 809 | 668 | 535 |
| Other current liabilities | 946 | 819 | 716 | 706 | 688 |
| TOTAL | $3,832 | $3,409 | $3,043 | $2,724 | $2,428 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,832 | $3,409 | $3,043 | $2,724 | $2,428 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,724 | 13,624 | 13,324 | 12,775 | 12,775 |
| Common Shares | 601 | 601 | 1 | 1 | 1 |
| Retained earnings | -114,532 | -114,703 | -112,883 | -111,444 | -110,834 |
| Other shareholders' equity | 0 | 0 | 600 | 0 | 0 |
| TOTAL | $-3,794 | $-3,362 | $-2,873 | $-2,174 | $-1,682 |
| Total Liabilities And Equity | $37 | $47 | $170 | $550 | $746 |